Selective COX‐2 inhibitors vs NSAIDs
Proportion of participants experiencing adverse events · Patients with acute low‐back pain
It is very uncertain whether selective COX‐2 inhibitors changes proportion of participants experiencing adverse events compared with non‐selective NSAIDs (very low certainty).
1 finding from 1 review
- Non‐steroidal anti‐inflammatory drugs for acute low back pain 2020 · Cochrane Headline outcomes onlyRR 0.97 [0.63, 1.5]2 studies · 444 participantsVery low